Hydrogen gas presents a promising therapeutic strategy for sepsis
- PMID: 24829918
- PMCID: PMC4009185
- DOI: 10.1155/2014/807635
Hydrogen gas presents a promising therapeutic strategy for sepsis
Abstract
Sepsis is characterized by a severe inflammatory response to infection. It remains a major cause of morbidity and mortality in critically ill patients despite developments in monitoring devices, diagnostic tools, and new therapeutic options. Recently, some studies have found that molecular hydrogen is a new therapeutic gas. Our studies have found that hydrogen gas can improve the survival and organ damage in mice and rats with cecal ligation and puncture, zymosan, and lipopolysaccharide-induced sepsis. The mechanisms are associated with the regulation of oxidative stress, inflammatory response, and apoptosis, which might be through NF- κ B and Nrf2/HO-1 signaling pathway. In this paper, we summarized the progress of hydrogen treatment in sepsis.
References
-
- Briegel J, Mohnle P. International guidelines of the Surviving Sepsis Campaign: update 2012. Der Anaesthesist. 2013;62(4):304–309. - PubMed
-
- Okazaki Y, Matsukawa A. Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Patents on Inflammation and Allergy Drug Discovery. 2009;3(1):26–32. - PubMed
-
- Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. The New England Journal of Medicine. 2012;367(2):124–134. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
